Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-1992 | 05-1992 | 02-1992 | 11-1991 | 08-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,876 | 1,777 | 635 | 924 | 390 |
| TOTAL | $1,876 | $1,777 | $635 | $924 | $390 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 2,092 | N/A | N/A |
| Other Non-Current Assets | 3,086 | 3,055 | 3,092 | 3,578 | 3,893 |
| TOTAL | $3,086 | $3,055 | $5,184 | $3,578 | $3,893 |
| Total Assets | $4,962 | $4,832 | $5,819 | $4,502 | $4,283 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 352 | 270 | 540 | 332 | 1,135 |
| Accrued Expenses | 2,058 | 1,758 | 2,145 | 2,514 | 1,996 |
| Other current liabilities | 3,815 | 4,049 | 541 | 455 | 298 |
| TOTAL | $8,192 | $7,929 | $4,453 | $4,805 | $4,442 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 323 | 307 | 284 | 238 | 207 |
| TOTAL | $323 | $307 | $284 | $238 | $207 |
| Total Liabilities | $8,515 | $8,236 | $4,737 | $5,043 | $4,649 |
| Shareholders' Equity | |||||
| Common Shares | 30,864 | 30,826 | 30,627 | 29,465 | 29,208 |
| TOTAL | $30,864 | $30,826 | $30,627 | $29,465 | $29,208 |
| Total Liabilities And Equity | $39,379 | $39,062 | $35,364 | $34,508 | $33,857 |